Piracetam vs Pramiracetam for focus
Short answer: For focus, more users report improvement with Pramiracetam — 95% of 91 reports, versus 80% of 458 for Piracetam.
Piracetam has 119 meta-analyses and 117 randomized trials on PubMed; Pramiracetam has 0 and 3.
Based on 1,463 reports about Piracetam and 343 about Pramiracetam. Not medical advice.
| Piracetam Supplement | Pramiracetam Supplement | |
|---|---|---|
| Users say it helped | 53%helped688 reports · high confidence | 59%helped127 reports · high confidence |
| Verdict | Mixed | Mixed |
| Research | AResearch: Strong | CResearch: Limited |
| Meta-analyses / RCTs | 119 / 117 | 0 / 3 |
| Mainly used for | ||
| Focus % reporting improvement | 80% (458) | 95% (91) |
| Memory % reporting improvement | 89% (241) | 95% (38) |
| Mood % reporting improvement | 74% (116) | 45% (22) |
| Energy % reporting improvement | 78% (69) | 91% (11) |
| Anxiety % reporting improvement | 86% (57) | 100% (8) |
| Common side effects | headache, drowsiness, irritability, insomnia | headache, emotional blunting, fatigue, bad taste |
| Typical dose reported | 250 mg / daily | 1 teaspoon |
High-level evidence related to pharmacological strategies for managing Lewy body dementia is rare. Strategies for important areas of need in Lewy body dementia, such as autonomic symptoms and caregiver burden, have not been investigated, nor have the views of patients and caregivers about pharmacological strategies.
Am J Psychiatry, 2015 ↗“The effects were wonderful, they still are to me-- verbal fluidity, increased motivation, quicker thinking, better recall, pro social, wake up in the morning with ZERO grogginess.”
“I was very anxious and listless for a while and the substances that helped me the most were Pramiracetam + alpha GPC.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate